Effects of Metformin on Hepatic Free Fatty Acid Metabolism in Patients Diagnosed With Type 2 Diabetes: A C11 PET Study
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Metformin (Primary)
- Indications Dyslipidaemias; Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 15 Oct 2019 Biomarkers information updated
- 13 Apr 2013 New source identified and integrated (European Clinical Trials Database: EudraCT2012-000808-16).
- 13 Apr 2013 Status changed from not yet recruiting to recruiting as reported by European Clinical Trials Database.